Radiometer logo

Understanding the physiology of human cutaneous microcirculation and its role as a surrogate biomarker

April 19, 2024

This webinar is sponsored by Perimed* .

Watch on-demand

About this webinar

Welcome to the first in our series of clinical assessment webinars: why measure microcirculation. In session #1, professor Jean-Luc Cracowski, MD, Ph.D., from Grenoble Alpes University, France, will provide an overview of microcirculation and its role in clinical assessment.

Variations in skin blood flow result from highly complex interactions between endothelial, myogenic and neuromuscular mechanisms. In this conference, we will detail the anatomy, physiology and pharmacology of the human skin microcirculation. We will then introduce the current methods of exploration. We will further discuss the part played by cutaneous microvascular impairment in the pathophysiology of systemic diseases and whether cutaneous microcirculation could be used as a surrogate biomarker.

Attendees will be provided with practical ways to detect these issues (for providers), and how to reduce the likelihood of their occurrence (for laboratorians).

Speaker:

Jean-Luc Cracowski
Professor of Pharmacology
Grenoble Alpes University, France

His primary research focus lies in exploring skin microcirculation, understanding the pathophysiology of microvascular diseases, and developing novel pharmacological approaches to treat conditions such as systemic sclerosis, Raynaud’s phenomenon, and diabetes. His h-index is 45 and have coauthored 287 publications indexed in Medline.

Can't make it?

This webinar will be available on-demand. Please register to receive the on-demand link.

*About Perimed

Perimed is a Swedish MedTech and innovator of peripheral vascular measurement solutions with over 40 years of development history. Radiometer is a distributor of Perimed’s PeriFlux 6000 tcpO2 stand-alone transcutaneous monitor.

Cookies are used on this website

Use of cookies
Confirm your account with Radiometer

Please enter a valid email

CONTINUE
By submitting your e-mail you agree to the data policy notice
Radiometer is using Microsoft Azure Active Directory to authenticate customer access. If you are already registered you will be taken to Microsoft AD to sign in using your Microsoft AD credentials.
You are already registered
Radiometer is using Microsoft Azure AD to authenticate customer access. If you are already registered you will be taken to AZURE to sign in using your AZURE credentials.
Thank you

We will be sending an e-mail invitation to you shortly to sign in using Microsoft Azure AD.

Radiometer is using Microsoft Azure AD to authenticate customer access.
Sorry

It seems that your e-mail is not registered with us

Radiometer is using Microsoft Azure AD to authenticate customer access. If your e-mail is not registered with us please click CONTINUE and we will guide you through the sign-in process.
We have previously sent an invitation by e-mail

Please click "Get started" in the e-mail to complete the registration process

Radiometer is using Microsoft Azure AD to authenticate customer access.
Sorry

We were not able to process your request due to a communication error

Sorry

It seems this account has not been given access to the portal

Radiometer is using Microsoft AZURE Active Directory to authenticate users

Radiometer uses Azure AD to provide our customers and partners secure access to documents, resources, and other services on our customer portal.

If your organization is already using Azure AD you can use the same credentials to access Radiometer's customer portal.

Key benefits

       
  • Allow the use of existing Active Directory credentials
  • Single-sign on experience
  • Use same credentials to access future services

Request access

You will receive an invitation to access our services via e-mail when your request has been approved.

When you accept the invitation, and your organization is already using AZURE AD, you can use the same credentials to access Radiometer's customer portal. Otherwise, a one-time password will be sent via e-mail to sign in.